Dr Adrian Bradley is a Partner at Cleveland Scott York. His practice is devoted to helping clients achieve their strategic goals by devising and implementing intellectual property strategies to support them.
His practice focusses on healthcare, with specialisms in medical devices and pharmaceuticals. Having trained as a patent attorney in the pharmaceutical industry with Wyeth (now Pfizer), Dr Bradley has a detailed knowledge of product lifecycle management in the sector. He has worked extensively on Supplementary Protection Certificates and advises on regulatory data exclusivity.
He has a particular interest in technology transfer, regularly advising academic institutions around the world on obtaining effective protection for their innovations through patents. His enthusiasm for technology transfer stems from a belief that pioneering medical innovations made in university research laboratories deserve to be in the hands of doctors and saving the lives of patients. He undertakes a significant amount of pro bono work in areas of unmet clinical need in developing countries, such as tuberculosis in India.
Dr Bradley has acted as lead IP counsel for many university spin-out companies, in areas as diverse as neurodegeneration (CholesteniX), anti-infectives (Lucilia), peptide synthesis, and image-guided medical procedures. He also acts as European counsel for a number of university research foundations in the United States, notably the University of Utah Research Foundation.
In addition to his technology transfer practice, Dr Bradley acts as European representative for a multinational medical device company. He has handled numerous matters of commercial significance, including oppositions and appeals at the European Patent Office, particularly in the field of minimally invasive surgical methods.
He is a member of the Business Advisory Board of the Institute of Organic Chemistry and Biochemistry (IOCB) in the Czech Republic, a visiting lecturer at the University of Reading, and has delivered many seminars and lectures on technology transfer (and other IP related subjects) in the UK, Europe, Asia and the United States. He is a member of the continuing professional development committee of the Chartered Institute of Patent Attorneys.
Pharmaceuticals, Agrochemicals Chemistry
Appeals oppositions before the EPO
Supplementary Protection Certificates
IAM 1000 & Strategy 300
MA Chemistry (1st class), Balliol College, Oxford
PhD Organic Chemistry, University College, London
Chartered Patent Attorney 2004
European Patent Attorney 2004
SCI (Society of Chemical Industry)